iTrack™ ab-interno canaloplasty offers implant-free, canal-based glaucoma surgery that achieves excellent clinical outcomes. iTrack™ removes all points of blockage in the outflow pathway, reducing IOP and dependence on medications. The iTrack microcatheter can be used in both ab-interno and ab-externo canaloplasty procedures for glaucoma treatment.

The iTrack™Advance improves the efficiency of the canaloplasty procedure, with an easy-to-use handpiece making the procedure faster to perform. The iTrack™ Advance connects to the iLumin illumination source.

iTrack™ ab-interno canaloplasty offers implant-free, canal-based glaucoma surgery, for all grades of glaucoma severity. iTrack™ removes all points of blockage in the outflow pathway, reducing IOP and dependence on medications. The iTrack Advance™ improves the efficiency of the canaloplasty procedure, with an easy-to-use handpiece making the procedure faster to perform. It is suitable for the treatment of mild to moderate glaucoma.

The iTrack™ Advance is the latest generation iTrack™ device, which was first introduced in 2008. Today, more than 150,000 iTrack™ procedures have been performed globally. 

Yes, the iTrack™ Advance procedure eliminates the need to remove or tear trabecular meshwork tissue. In addition, it preserves the conjunctiva and angle for any future procedures, if required.

The iTrack™ Advance is designed to treat mild to moderate cases of glaucoma.

Yes, iTrack™ Advance enables titration of OVD volume based on the patient’s pathology. It is the only canaloplasty device that enables surgeons to customise the degree of viscodilation on an individual patient basis, maximising patient outcomes.

Shear Clear™ Technology is iTrack™ Advance’s proprietary technology that maximizes shear thinning to transform viscoelastic rheology during canaloplasty. The patented internal micro-architecture of the microcatheter, including a woven nitinol guidewire, is designed to generate controlled turbulence that maximizes shear stress. The ViscoInjector™ connects to the microcatheter via a 24-inch-long infusion line, through which viscoelastic is pushed under high pressure to maximize shear stress.

Viscoelastic shearing, or shear thinning, is how viscoelastic temporarily changes viscosity under the high shear stresses generated by Shear Clear™ Technology.

1. At rest, cohesive viscoelastic behaves like a high-viscosity gel.
2. Shear forces in iTrackTM Advance temporarily transform the viscoelastic into a fluid-like state.
3. Shear forces are released, returning the viscoelastic to its original gel-like state.

The core product technology of the iTrack™ Advance and the technique for the surgeon and nursing staff remains unchanged. Further to this, the indications for use and regulatory clearance remain unchanged. A new-look ‘Green light’ iTrack Advance handpiece has been developed and a new iLumin Lightbox is also now available giving a green guiding light instead of red. Both iLumin variants work with both iTrack devices and the colour of the light is determined by the iLumin lightbox rather than the handheld iTrack Advance.

The iTrack™ Advance combines 360° microcatheterisation and viscodilation to address all potential points of resistance in the conventional outflow pathway, including; the trabecular meshwork, Schlemm’s canal and the collector channels – and thereby removes the guesswork inherent in stent based MIGS procedures.

Initially 15-20 minutes, although once the user is fully trained, it can be as quick as five minutes.

Yes, the iTrack™ Advance can be used on an eye which already has an iStent in place.

No, the lightbox does not need to be sterilized, it can just be sterile wiped.

No, the iLumin illumination source is a battery-powered device; there is no power cable.

Yes, the iTrack™ Advance is used once and then disposed of.

The iTrack™ Advance can treat double the area of OMNI and delivers 20 times more OVD.

For price information, including a full quotation, please contact the customer services team on 01279 883720 or email info.unitedkingdom@haag-streit.com.

Yes, please contact the customer services team on info.unitedkingdom@haag-streit.com or call 01279 883720 and we can arrange a demonstration of the device for you.

The iTrack is manufactured by Nova Eye Medical, a company based in California, USA, with a global network of more than 50 distribution partners. Nova Eye's legacy spans more than 30 years in ophthalmology, with a portfolio of proprietary glaucoma treatment technologies. Haag-Streit UK is the sole UK Distributor for the Nova Eye iTrack™ Advance.